Relation of Drug-Eluting Stent Strut Distribution to Stent Thrombosis in Coronary Arteries

American Journal of Cardiology

Volumn 104, Issue 3, 2009, Pages 343-348

  Opolski, Maksymilian P ^a   Pracon, Radoslaw ^a   Mintz, Gary S ^b   Okabe, Teruo ^a   Pregowski, Jerzy ^c   Lee, Sung Yun ^a   van der Waal, Eva C ^a   Kalinczuk, Lukasz ^c   Roy, Probal ^a   Smith, Kimberly A ^a   Torguson, Rebecca ^a   Xue, Zhenyi ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Pichard, Augusto D ^a   Waksman, Ron ^a   Weissman, Neil J ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^c INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; PACLITAXEL; RAPAMYCIN;

ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY STENT; DRUG ELUTING STENT; FEMALE; HUMAN; INCIDENCE; INTRAVASCULAR ULTRASOUND; MALE; PRIORITY JOURNAL; STENT THROMBOSIS;

AGED; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 67651109083     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.03.047     Document Type: Article

References (30)

1. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., Jaeger J.L., Kuntz R.E., and SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
2. Colombo A., Drzewiecki J., Banning A., Grube E., Hauptmann K., Silber S., Dudek D., Fort S., Schiele F., Zmudka K., Guagliumi G., Russell M.E., and TAXUS II Study Group. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 108 (2003) 788-794
3. Iakovou I., Schmidt T., Bonizzoni E., Ge L., Sangiorgi G.M., Stankovic G., Airoldi F., Chieffo A., Montorfano M., Carlino M., Michev I., Corvaja N., Briguori C., Gerckens U., Grube E., and Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
4. Kuchulakanti P.K., Chu W.W., Torguson R., Ohlmann P., Rha S.W., Clavijo L.C., Kim S.W., Bui A., Gevorkian N., Xue Z., Smith K., Fournadjieva J., Suddath W.O., Satler L.F., Pichard A.D., Kent K.M., and Waksman R. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113 (2006) 1108-1113
5. Ong A.T., McFadden E.P., Regar E., de Jaegere P.P., van Domburg R.T., and Serruys P.W. Late angiographic stent thrombosis events with drug eluting stents. J Am Coll Cardiol 45 (2005) 2088-2092
6. McFadden E.P., Stabile E., Regar E., Cheneau E., Ong A.T., Kinnaird T., Suddath W.O., Weissman N.J., Torguson R., Kent K.M., Pichard A.D., Satler L.F., Waksman R., and Serruys P.W. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364 (2004) 1519-1521
7. Jeremias A., Sylvia B., Bridges J., Kirtane A.J., Bigelow B., Pinto D.S., Ho K.K., Cohen D.J., Garcia L.A., Cutlip D.E., and Carrozza J.P. Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 109 (2004) 1930-1932
8. Moreno R., Fernandez C., Hernandez R., Alfonso F., Angiolillo D.J., Sabate M., Escaned J., Banuelos C., Fernandez-Ortiz A., and Macaya C. Drug-eluting stent thrombosis. Results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 45 (2005) 954-959
9. Waters R.E., Kandzari D.E., Phillips H.R., Crawford L.E., and Sketch M.H. Late thrombosis following treatment of in-stent restenosis with drug eluting stents after discontinuation of antiplatelet therapy. Catheter Cardiovasc Interv 65 (2005) 520-524
10. Sonoda S., Morino Y., Ako J., Terashima M., Hassan A.H., Bonneau H.N., Leon M.B., Moses J.W., Yock P.G., Honda Y., Kuntz R.E., Fitzgerald P.J., and SIRIUS Investigators. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the SIRIUS trial. J Am Coll Cardiol 43 (2004) 1959-1963
11. Fujii K., Carlier S.G., Mintz G.S., Yang Y.M., Moussa I., Weisz G., Dangas G., Mehran R., Lansky A.J., Kreps E.M., Collins M., Stone G.W., Moses J.W., and Leon M.B. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 45 (2005) 995-998
12. Okabe T., Mintz G.S., Buch A.N., Roy P., Hong Y.J., Smith K.A., Torguson R., Gevorkian N., Xue Z., Satler L.F., Kent K.M., Pichard A.D., Weissman N.J., and Waksman R. Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment. Am J Cardiol 100 (2007) 615-620
13. Virmani R., Guagliumi G., Farb A., Musumeci G., Grieco N., Motta T., Mihalcsik L., Tespili M., Valsecchi O., and Kolodgie F.D. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent. Should we be cautious?. Circulation 109 (2004) 701-705
14. Sakurai R., Ako J., Morino Y., Sonoda S., Kaneda H., Terashima M., Hassan A.H., Leon M.B., Moses J.W., Popma J.J., Bonneau H.N., Yock P.G., Fitzgerald P.J., Honda Y., and SIRIUS Trial Investigators. Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). Am J Cardiol 96 (2005) 1251-1253
15. Cook S., Wenaweser P., Togni M., Billinger M., Morger C., Seiler C., Vogel R., Hess O., Meier B., and Windecker S. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 115 (2007) 2426-2434
16. Schwarzmaier-D'Assie A., Karnik R., Bonner G., Vavrik J., and Slany J. Fracture of a drug-eluting stent in the tibioperoneal trunk following bifurcation stenting. J Endovasc Ther 14 (2007) 106-109
17. Yagi S., Kimura T., Hayashi I., and Nishiuchi T. Acute coronary syndrome due to hinge movement of a bare-metal stent. Int J Cardiol 123 (2008) e64-e66
18. Shite J., Matsumoto D., and Yokoyama M. Sirolimus-eluting stent fracture with thrombus, visualization by optical coherence tomography. Eur Heart J 27 (2006) 1389
19. Hasegawa T., Ako J., Ikeno F., Waseda K., Suzuki Y., Honda Y., and Fitzgerald P.J. Comparison of nonuniform strut distribution between two drug-eluting stent platforms. J Invasive Cardiol 19 (2007) 244-246
20. Takebayashi H., Mintz G.S., Carlier S.G., Kobayashi Y., Fujii K., Yasuda T., Costa R.A., Moussa I., Dangas G.D., Mehran R., Lansky A.J., Kreps E., Collins M.B., Colombo A., Stone G.W., Leon M.B., and Moses J.W. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation 110 (2004) 3430-3434
21. Sano K., Mintz G.S., Carlier S.G., Fujii K., Takebayashi H., Kimura M., Costa Jr. J.R., Tanaka K., Costa R.A., Lui J., Weisz G., Moussa I., Dangas G.D., Mehran R., Lansky A.J., Kreps E.M., Collins M., Stone G.W., Moses J.W., and Leon M.B. Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosis. Am J Cardiol 98 (2006) 1559-1562
22. Mintz G.S. Features and parameters of drug-eluting stent deployment discoverable by intravascular ultrasound. Am J Cardiol 100 suppl (2007) 26M-35M
23. Mintz G.S., Nissen S.E., Anderson W.D., Bailey S.R., Erbel R., Fitzgerald P.J., Pinto F.J., Rosenfield K., Siegel R.J., Tuzcu E.M., and Yock P.G. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American College of Cardiology task force on clinical expert consensus documents. J Am Coll Cardiol 37 (2001) 1478-1492
24. Uren N.G., Schwarzacher S.P., Metz J.A., Lee D.P., Honda Y., Yeung A.C., Fitzgerald P.J., Yock P.G., and POST Registry Investigators. Predictors and outcomes of stent thrombosis. An intravascular ultrasound registry. Eur Heart J 23 (2002) 124-132
25. Lee S.H., Park J.S., Shin D.G., Kim Y.J., Hong G.R., Kim W., and Shim B.S. Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation. Am J Cardiol 100 (2007) 628-630
26. Cheneau E., Leborgne L., Mintz G.S., Kotani J., Pichard A.D., Satler L.F., Canos D., Castagna M., Weissman N.J., and Waksman R. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation 108 (2003) 43-47
27. Kim S.W., Mintz G.S., Ohlmann P., Hassani S.E., Fernandez S., Lu L., Chu W.W., Escolar E., Kuchulakanti P.K., Weigold G., Pichard A.D., Satler L.F., Kent K.M., Suddath W.O., Waksman R., and Weissman N.J. Frequency and severity of plaque prolapse within Cypher and Taxus stents as determined by sequential intravascular ultrasound analysis. Am J Cardiol 98 (2006) 1206-1211
28. Joner M., Finn A.V., Farb A., Mont E.K., Kolodgie F.D., Ladich E., Kutys R., Skorija K., Gold H.K., and Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
29. Matsumoto D., Shite J., Shinke T., Otake H., Tanino Y., Ogasawara D., Sawada T., Paredes O.L., Hirata K., and Yokoyama M. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 28 (2007) 961-967
30. Finn A.V., Joner M., Nakazawa G., Kolodgie F., Newell J., John M.C., Gold H.K., and Virmani R. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115 (2007) 2435-2441